1. Report Introduction 2. Radiation Toxicity Overview 3. Pipeline Therapeutics • An Overview of Pipeline Products for Radiation Toxicity 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 7. Therapeutic Assessment • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About DelveInsight

Table 1: Total Products for Radiation Toxicity Table 2: Products in Clinical Stage Table 3: Products in Non-clinical Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Radiation Toxicity Figure 2: Products in Clinical Stage Figure 3: Products in Non-clinical Stage Figure 4: Assessment by Route of Administration Figure 5: Assessment by Stage and Route of Administration Figure 6: Assessment by Molecule Type Figure 7: Assessment by Stage and Molecule Type Figure 8: Inactive Products

Aeolus Pharmaceuticals Inc Angion Biomedica Corp Atox Bio Ltd BCN Biosciences LLC Bolder Biotechnology Inc Cellerant Therapeutics Inc Cellphire Inc Chrysalis BioTherapeutics Inc Cleveland BioLabs Inc Daiichi Sankyo Company Ltd FirstString Research Inc Foresee Pharmaceuticals LLC Galera Therapeutics Inc GSK:Genzyme Corp GNI Group Ltd Humanetics Corp Insys Therapeutics Inc & list continues…